Pharmacogenomics, the study of the role of genetics in drug response, has become a vital resource in battling disease and improving outcomes. As our knowledge of the human genome grows, and with the advent of next-generation sequencing technologies, the role of genetic research is evolving guide therapy, mitigate treatment side effects, and even prevent or alleviate harm for disease. As pivotal members of the healthcare team, nurses must acquire competency in pharmacogenomics to deliver optimal patient care in the 21st century.
Mastering Pharmacogenomics provides nursing professionals with the foundational knowledge of human genetics and genomics that can optimize drug therapy and patient care delivery.
- Essential pharmacogenomics competencies for registered nurses
- Genomics technologies and resources
- Critical properties of drug response and disposition
- Application of pharmacogenomics to obstetrics, pediatrics, geriatrics, and oncology
- Ethics and patient care
- Future developments in technology and delivery
Doody 4 Star Review
“As a "handbook for success" for nurses, this is not a complex scientific treatise presenting research. It presents helpful information designed to be used and referenced by clinicians in practice, much like a drug handbook. The book is easy to understand and meant, for example, for bedside nurses who assess patients and administer medications and nurses who prescribe the medications. By improving our knowledge and understanding of pharmacogenomics, we can improve patient outcomes.”
-Carol Agana, MNSc, CNP, APRN (University of Arkansas)
©Doody’s Review Service™
About the Authors
Dale Halsey Lea, MPH, RN, CGC, APNG, is an Advanced Practice Nurse in Genetics and a Board Certified Genetic Counselor. She is a founding member of the International Society of Nurses in Genetics.
Dennis J. Cheek, PhD, RN, FAHA, is the Abell-Hanger professor in Gerontological Nursing at Texas Christian University Harris College of Nursing and Health Sciences, with a joint appointment in the School of Nurse Anesthesia.
Daniel Brazeau, PhD, is Director of the University of New England’s Genomics, Analytics and Proteomics Core (GAPc) and a Research Associate Professor in the Department of Pharmaceutical Sciences, College of Pharmacy.
Gayle A. Brazeau, PhD, Dean and Professor in the College of Pharmacy at the University of New England, is Editor for the American Journal of Pharmaceutical Education.